These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3924624

  • 1. Thiotepa versus adriamycin versus cis-platinum in the intravesical prophylaxis of superficial bladder tumors.
    Llopis B, Gallego J, Mompó JA, Boronat F, Jiménez JF.
    Eur Urol; 1985; 11(2):73-8. PubMed ID: 3924624
    [Abstract] [Full Text] [Related]

  • 2. [Superficial bladder cancer: prophylaxis of recurrence and progression].
    Miyanaga N, Akaza H, Koiso K.
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2369-74. PubMed ID: 1719939
    [Abstract] [Full Text] [Related]

  • 3. Crossed chemoprophylaxis assay between adriamycin and cis-platinum in recurrent superficial bladder tumor.
    Llopis B, Gallego J, Mompó JA, Boronat F, Alonso M, Moreno B, Jiménez JF.
    Eur Urol; 1986 Nov; 12(4):253-6. PubMed ID: 3091370
    [Abstract] [Full Text] [Related]

  • 4. Intravesical thiotepa prophylaxis of superficial bladder cancer. A follow-up study.
    Fosså SD, Miller A, Stenwig AE.
    Eur Urol; 1983 Nov; 9(4):207-10. PubMed ID: 6409615
    [Abstract] [Full Text] [Related]

  • 5. The role of intravesical thiotepa in the management of superficial bladder cancer. National Bladder Cancer Collaborative Group A.
    Cancer Res; 1977 Aug; 37(8 Pt 2):2916-7. PubMed ID: 406040
    [Abstract] [Full Text] [Related]

  • 6. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS, Chow NH, Lin JS, Yang WH, Tong YC.
    Anticancer Res; 1998 Aug; 18(6B):4717-21. PubMed ID: 9891547
    [Abstract] [Full Text] [Related]

  • 7. [Comparative study of thiotepa, adriamycin and cisplatin in the prophylaxis of recurrence of superficial bladder carcinoma in a group of 217 patients].
    Llopis B, Gallego J, Boronat F, Moreno B, Mompó JA, Jiménez JF.
    Actas Urol Esp; 1986 Aug; 10(4):225-30. PubMed ID: 3092589
    [No Abstract] [Full Text] [Related]

  • 8. [Postoperative prophylactic intravesical instillation of tetrahydropyranyl-adriamycin (THP) for superficial bladder cancer].
    Kanayama H, Yokota K, Kurokawa Y, Kagawa S, Yokozeki H, Inai T, Ogawa I, Akazawa S, Hashimoto H, Mizuta K.
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):651-5. PubMed ID: 10234296
    [Abstract] [Full Text] [Related]

  • 9. Adjuvant chemotherapy of recurrent superficial transitional cell carcinoma: results of a European organization for research on treatment of cancer randomized trial comparing intravesical instillation of thiotepa, doxorubicin and cisplatin. The European Organization for Research on Treatment of Cancer Genitourinary Group.
    Bouffioux C, Denis L, Oosterlinck W, Viggiano G, Vergison B, Keuppens F, De Pauw M, Sylvester R, Cheuvart B.
    J Urol; 1992 Aug; 148(2 Pt 1):297-301. PubMed ID: 1635122
    [Abstract] [Full Text] [Related]

  • 10. [Preliminary results of a randomized study between intravesical adriamycin and thio-tepa in the treatment of superficial tumors of bladder].
    Allona Moncada A, Santos García Vaquero I, Polo Villar G, Díaz González R, González Martín M, Zuloaga Gómez A, Martínez Torres JL, Rodríguez Alvarez J, Duarte Vázquez JJ, Megino López JF.
    Arch Esp Urol; 1984 Aug; 37(2):113-22. PubMed ID: 6431914
    [No Abstract] [Full Text] [Related]

  • 11. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M, McGarry R, Kupelnick B.
    Anticancer Res; 2001 Aug; 21(1B):765-9. PubMed ID: 11299841
    [Abstract] [Full Text] [Related]

  • 12. Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors.
    Pavone-Macaluso M, Tripi M, Ingargiola GB.
    Cancer Chemother Pharmacol; 1983 Aug; 11 Suppl():S16-21. PubMed ID: 6416698
    [Abstract] [Full Text] [Related]

  • 13. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
    Mobley WC, Loening SA, Narayana AS, Culp DA.
    Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
    [Abstract] [Full Text] [Related]

  • 14. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.
    Martínez-Piñeiro JA, Jiménez León J, Martínez-Piñeiro L, Fiter L, Mosteiro JA, Navarro J, García Matres MJ, Cárcamo P.
    J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041
    [Abstract] [Full Text] [Related]

  • 15. [Adrianycin as intracavitary coadjuvant treatment of superficial bladder tumors. Our initial experiences].
    Martínez Lasierra M, Caro Cebrián C, Sanz Vélez JI, Roncalés A, Rioja Sanz C.
    Actas Urol Esp; 1981 Mar; 5(4):219-22. PubMed ID: 6797270
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder.
    Pan JS, Slocum HK, Rustum YM, Greco WR, Gaeta JF, Huben RP.
    J Urol; 1989 Dec; 142(6):1589-93. PubMed ID: 2511340
    [Abstract] [Full Text] [Related]

  • 17. Intravesical thiotepa in prevention of recurrence of bladder tumour.
    Ghosal SK, Sen DK.
    J Indian Med Assoc; 1980 Nov 01; 75(9):173-4. PubMed ID: 6785360
    [No Abstract] [Full Text] [Related]

  • 18. [Characteristic and effective usage of adriamycin].
    Horiuchi K, Akimoto M.
    Gan To Kagaku Ryoho; 1996 Dec 01; 23(14):1916-9. PubMed ID: 8978797
    [Abstract] [Full Text] [Related]

  • 19. [Progress in the internist treatment of bladder tumors].
    Baumgartner G.
    Wien Med Wochenschr; 1982 Jul 31; 132(13-14):305-12. PubMed ID: 6814073
    [Abstract] [Full Text] [Related]

  • 20. [Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer--the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin].
    Hinotsu S, Akaza H, Isaka S, Kagawa S, Koiso K, Kotake T, Machida T, Matsumura Y, Niijima T, Obata K, Ohashi Y, Ohe H, Shimazaki J, Tashiro K, Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin.
    Gan To Kagaku Ryoho; 2002 Jan 31; 29(1):73-80. PubMed ID: 11816482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.